Tele-Yoga Therapy for Chronic Pain

Sponsor
Aarogyam UK (Other)
Overall Status
Completed
CT.gov ID
NCT04457388
Collaborator
(none)
18
1
1
2.7
6.7

Study Details

Study Description

Brief Summary

Chronic pain is highly prevalent and associated with a large symptom burden, that is had been more concerning during Covid-19 outbreak and lockdown. Benefits of yoga in chronic pain management are very well known. With this background we developed Tele-Yoga therapy program and evaluated the success of this single arm study.

Condition or Disease Intervention/Treatment Phase
  • Other: Tele-Yoga Therapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Tele- Yoga Therapy for Patients With Chronic Pain During Covid-19 Lockdown: A Prospective Non-randomized Single Arm Clinical Trial
Actual Study Start Date :
Mar 25, 2020
Actual Primary Completion Date :
Jun 15, 2020
Actual Study Completion Date :
Jun 15, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tele-Yoga Therapy

Individualised Yoga therapy based on participant's clinical condition and personal needs. Twice a week sessions were carried out by trained and experienced Yoga therapist via video conference with each therapy for individualized based on each participant.

Other: Tele-Yoga Therapy
Yoga practices combining with joint loosening exercises (Sukshma Vyayama), postures (Asana), breathing exercises (Pranayama), relaxation techniques and chanting ( A, U, M, and AUM { ૐ}) syllable chants meditation. Each session ended with home practice exercises given to the participants to practice everyday.

Outcome Measures

Primary Outcome Measures

  1. Pain Intensity [From baseline to 6-week post intervention]

    visual-analogic scale (VAS), using pain level from "no pain" (0) to "worst imaginable pain" (10)

Secondary Outcome Measures

  1. Pain Disability [From baseline to 6-week post intervention]

    Pain Disability Index (PDI) using seven rating scales, structured in Likert form, from "no disability" (0) to "worst disability" (10)

  2. Anxiety [From Baseline to 6-week post intervention]

    Hospital Anxiety Depression Scale, consisting of 7 scales for measuring anxiety levels

  3. Depression [From baseline to 6-week post intervention]

    Hospital Anxiety Depression Scale, consisting of 7 scales for measuring depression levels

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Chronic pain for at least 3 months

  • Having access to internet and video calls

Exclusion Criteria:
  • Pregnant or breast-feeding women,

  • Patients not willing to give written consent

  • Patients with severe psychiatric or personality disorder

  • Malignancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aarogyam UK Leicester Leicestershire United Kingdom

Sponsors and Collaborators

  • Aarogyam UK

Investigators

  • Principal Investigator: Neha Sharma, Aarogyam UK
  • Study Chair: Dipa Modi, Aarogyam UK
  • Study Chair: Bhavna Pandya, Aarogyam UK

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aarogyam UK
ClinicalTrials.gov Identifier:
NCT04457388
Other Study ID Numbers:
  • AU/018
First Posted:
Jul 7, 2020
Last Update Posted:
Jul 8, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aarogyam UK
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2020